Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.
about
Mycophenolate mofetil (MMF) for the treatment of connective tissue disease-associated interstitial lung disease (ILD)Immunotherapy of systemic sclerosisManagement of Systemic-Sclerosis-Associated Interstitial Lung DiseaseMycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis employing confocal laser scanning microscopy: an objective outcome measure for clinical trials?Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosisMycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience.Scleroderma lung diseaseSystemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design.Lung involvement in systemic sclerosis.Mycophenolate mofetil for interstitial lung disease in dermatomyositis.Review: interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis: how similar and distinct?Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic reviewEffect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: a meta-analysisSystemic sclerosis disease modification clinical trials design: quo vadis?Old medications and new targeted therapies in systemic sclerosis.Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease.Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysisLong-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis.Therapies for interstitial lung disease: past, present and future.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesEvidence-based management of rapidly progressing systemic sclerosis.Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?Treatment of interstitial lung diseases associated with connective tissue diseases.Systemic sclerosis--challenges for clinical practice.Connective Tissue Disease-Associated Interstitial Lung Disease: A Focused Review.Early systemic sclerosis-opportunities for treatment.Cytokines in the immunopathology of systemic sclerosis.Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease.Strategy for treatment of fibrosis in systemic sclerosis: Present and future.Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease.Effect and safety of mycophenolate mofetil in idiopathic pulmonary fibrosisTreatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.Recent advances in the management of juvenile systemic sclerosis.Pathogenesis of systemic sclerosis-current concept and emerging treatments.Rituximab in early systemic sclerosis.Mycophenolate versus cyclophosphamide for progressive interstitial lung disease associated with systemic sclerosis: a 2-year case control study.Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.
P2860
Q24203019-CDF13FD0-24C9-4C82-95DB-6C47596550C8Q24634395-5084B258-6C7C-4C12-A8B2-4CFE66D32AA2Q26799573-FA957C06-5CCB-4EC7-ADD8-E432470F620DQ33434238-FE892D99-A3C5-4350-8780-FBD7E2355A01Q33536943-5195E121-F149-474B-BC10-52A88A9E8172Q33602730-BE95C10A-77FB-4BE1-AF8D-006F9E63446CQ33727800-6788F240-390C-4DB5-B841-0FD1FFF12F01Q33919119-56DB6525-F9F3-4415-89D2-922527745D0CQ34027197-E0294D42-494E-4CD1-9443-E0AB65773B1FQ34732817-E78F7747-00AC-4DEE-A6E3-4121865C5ABDQ34904088-084C92BB-4A4D-4C69-9F1E-D8A87AADB292Q35121494-58CB7590-9F20-4640-9EE3-E84E6896AEEDQ35560664-5AA75732-6EE2-4CB9-9C0D-FE17487FCDFBQ35977704-57B7A335-B654-4964-8335-B5D33676AC67Q36067226-CD9F517B-3D0D-460E-AD7C-370041F87069Q36154430-51CF11DF-1DB3-4774-BEE1-D02CD4737907Q36664408-9CCE92DA-7067-46B7-A705-8578BDB7AC73Q36913821-8A2FE23B-0655-475B-86D1-DE97072791B9Q36960060-F11E871B-E166-42F2-B821-0FD9435F7562Q37310075-AAA09715-6480-40D0-AD0C-7F98179F50E6Q37362642-D73F2FB1-9B0D-4B8C-8F3F-D23C74C69A15Q37381549-72F8E5C5-B6D3-4EF5-8250-5289F174762FQ37763779-5B8A2D9D-0650-4220-B91A-7D41AD23A91CQ37782153-675D17EB-187C-43A7-8A91-A8B8C2F2A00CQ37845609-1262DAEC-A79C-4975-BF6E-1005D16CA103Q37990559-AC3B6D2F-DE15-4390-B3CE-18DAF48E81D9Q38059459-A6FE2AAB-F3FE-495B-B109-58FD779B4531Q38174050-CCACA7A2-CC96-454D-8543-0908086FAE19Q38364855-CB1F7813-F006-428E-B354-BA29DE7EA222Q38543692-73AD1F3D-8B6F-414E-BD18-DC94DB42C693Q38692232-99B0417D-2992-4BE9-9C3F-FCD2D2D0A9ACQ38701990-D7912618-63D5-4C27-A333-24881D62F314Q38880396-4FB8B136-7B5C-4EC9-81BB-6B94F0AB56A6Q38909490-7C3FB90C-3142-4985-9263-04C5D652F2A5Q38936954-BC347D45-BC37-4DFD-AEB8-1445E2D95AF3Q38969038-96F04F0C-F975-4F02-B4BA-619A302B06F7Q39294794-A3790DA4-F81B-4EA8-8B37-A546C39E5C6EQ41544232-CF5E673E-D885-4E9F-A1CB-85F5D0FED2F5Q45167705-F806A553-E5DE-4333-8D7D-67BE71DEA1A0Q46662148-0F057522-5435-4773-B04C-AD58F624F185
P2860
Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Effect of mycophenolate mofeti ...... ted interstitial lung disease.
@en
Effect of mycophenolate mofeti ...... ted interstitial lung disease.
@nl
type
label
Effect of mycophenolate mofeti ...... ted interstitial lung disease.
@en
Effect of mycophenolate mofeti ...... ted interstitial lung disease.
@nl
prefLabel
Effect of mycophenolate mofeti ...... ted interstitial lung disease.
@en
Effect of mycophenolate mofeti ...... ted interstitial lung disease.
@nl
P356
P1433
P1476
Effect of mycophenolate mofeti ...... ated interstitial lung disease
@en
P2093
Anthony J Gerbino
Jerry A Molitor
P304
P356
10.1378/CHEST.06-2861
P407
P577
2007-12-10T00:00:00Z